Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, has announced that its ground-breaking X100HT device with Peripheral Blood Smear (PBS) Application has received US FDA 510(k) clearance.
Află mai multe aici.
Mesaj [Scopio în AIMed] Înlocuirea microscoapelor cu digitizare a apărut în primul rând pe Blogul nostru de mulțime.